Nerve Regeneration Market Research Report Information By Product (Neurostimulation & Neuromodulation Devices, Biomaterials), By Application (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

1 Market Introduction

1.1 Definition 17

1.2 Scope of the Study 17

1.3 Market Structure 17

2 Research Methodology

2.1 Research Process 18

2.2 Primary Research 19

2.3 Secondary Research 20

2.4 Market Size Estimation 21

2.5 Forecast Model 21

3 Market Dynamics

3.1 Introduction 22

3.2 Drivers 23

3.2.1 Rising Neurological Disorders 23

3.2.2 Increasing Geriatric Population 23

3.2.3 Technological Advancements 23

3.3 Restraints 24

3.3.1 Stringent Regulatory Framework 24

3.3.2 High Cost 24

3.4 Opportunity 24

3.4.1 Entering Developing Economies 24

4 Market Factor Analysis

4.1 Value Chain Analysis 25

4.1.1 Research and Development 25

4.1.2 Manufacturing 25

4.1.3 Distribution & Sales 26

4.1.4 Post-Sales Monitoring 26

4.2 Porter’s Five Forces Model 27

4.2.1 Threat of New Entrants 27

4.2.2 Bargaining Power of Suppliers 27

4.2.3 Bargaining Power of Buyers 28

4.2.4 Threat of Substitutes 28

4.2.5 Intensity of Rivalry 28

4.4 Pricing Analysis 29

5 Global Nerve Regeneration Market, by Product

5.1 Introduction 30

5.2 Neurostimulation and Neuromodulation Devices 32

5.2.1 Internal Neurostimulation Devices 33

5.2.2 External Neurostimulation Devices 34

5.3 Biomaterials 35

6 Global Nerve Regeneration Market, by Application

6.1 Introduction 37

6.2 Neurostimulation and Neuromodulation Surgeries 39

6.3 Direct Nerve Repair/Neurorrhaphy 41

6.4 Nerve Grafting 42

6.5 Stem Cell Therapy 43

7 Global Nerve Regeneration Market, by End User

7.1 Introduction 44

7.2 Hospitals and Clinics 45

7.3 Ambulatory Surgery Centers 46

8 Global Nerve Regeneration Market, by Region

8.1 Overview 47

8.2 Americas 48

8.2.1 North America 53

8.2.1.1 US 58

8.2.1.2 Canada 63

8.2.2 South America 67

8.3 Europe 72

8.3.1 Western Europe 77

8.3.1.1 Germany 82

8.3.1.2 France 87

8.3.1.3 Italy 91

8.3.1.4 Spain 96

8.3.1.5 UK 100

8.3.1.6 Rest of Western Europe 105

8.3.2 Eastern Europe 109

8.4 ASIA–PACIFIC 114

8.4.1 China 119

8.4.2 Japan 124

8.4.3 India 128

8.4.4 South Korea 133

8.4.5 Australia 137

8.4.6 Rest of Asia-Pacific 142

8.5 Middle East & Africa 147

8.5.1 Middle East 152

8.5.2 Africa 157

9 Company Landscape

9.1 Company Share Analysis 162

10 Company Profile

10.1 Boston Scientific Corporation 164

10.1.1 Company Overview 164

10.1.2 Financial Overview 164

10.1.3 Products/Services Offered 165

10.1.4 Key Developments 165

10.1.5 SWOT Analysis 166

10.1.6 Key Strategies 166

10.2 LivaNova PLC 167

10.2.1 Company Overview 167

10.2.2 Financial Overview 167

10.2.3 Products/Services Offered 168

10.2.4 Key Developments 168

10.2.5 SWOT Analysis 168

10.2.6 Key Strategies 168

10.3 Axogen Corporation 169

10.3.1 Company Overview 169

10.3.2 Financial Overview 169

10.3.3 Products/Services Offered 169

10.3.4 Key Developments 170

10.3.5 SWOT Analysis 170

10.3.6 Key Strategies 170

10.4 Integra LifeSciences 171

10.4.1 Company Overview 171

10.4.2 Financial Overview 171

10.4.3 Products/Services Offered 172

10.4.4 Key Developments 173

10.4.5 SWOT Analysis 173

10.4.6 Key Strategies 173

10.5 Abbott 174

10.5.1 Company Overview 174

10.5.2 Financial Overview 174

10.5.3 Products/Services Offered 175

10.5.4 Key Developments 175

10.5.5 SWOT Analysis 175

10.5.6 Key Strategies 176

10.6 Stryker Corporation 177

10.6.1 Company Overview 177

10.6.2 Financial Overview 177

10.6.3 Products/Services Offered 178

10.6.4 Key Developments 178

10.6.5 SWOT Analysis 178

10.6.6 Key Strategies 179

10.7 Nuvectra Corporation 180

10.7.1 Company Overview 180

10.7.2 Financial Overview 180

10.7.3 Products/Services Offered 180

10.7.4 Key Developments 181

10.7.5 SWOT Analysis 181

10.7.6 Key Strategies 181

10.8 NeuroPace 182

10.8.1 Company Overview 182

10.8.2 Financial Overview 182

10.8.3 Products/Services Offered 182

10.8.4 Key Developments 182

10.8.5 SWOT Analysis 183

10.8.6 Key Strategies 183

10.9 Polyganics 184

10.9.1 Company Overview 184

10.9.2 Financial Overview 184

10.9.3 Products/Services Offered 184

10.9.4 Key Developments 184

10.9.5 SWOT Analysis 185

10.9.6 Key Strategies 185

10.10 Medtronic 186

10.10.1 Company Overview 186

10.10.2 Financial Overview 186

10.10.3 Products/Services Offered 187

10.10.4 Key Developments 187

10.10.5 SWOT Analysis 188

10.10.6 Key Strategies 188

11 Appendix

11.1 References 189

11.2 Related Reports 189

12 List of Tables

TABLE 1 GLOBALNERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 31

TABLE 2 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 32

TABLE 3 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY REGION,

2023–2030 (USD MILLION) 32

TABLE 4 GLOBAL NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 33

TABLE 5 GLOBAL NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 34

TABLE 6 GLOBAL NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 35

TABLE 7 GLOBAL NERVE REGENERATION MARKET FOR BIOMATERIALS, BY REGION, 2023–2030 (USD MILLION) 36

TABLE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 38

TABLE 9 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 39

TABLE 10 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY REGION,

2023–2030 (USD MILLION) 40

TABLE 11 GLOBAL NERVE REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY REGION,

2023–2030 (USD MILLION) 41

TABLE 12 GLOBAL NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 42

TABLE 13 GLOBAL NERVE REGENERATION MARKET FOR NERVE GRAFTING, BY REGION, 2023–2030 (USD MILLION) 42

TABLE 14 GLOBAL NERVE REGENERATION MARKET FOR STEM CELL THERAPY, BY REGION, 2023–2030 (USD MILLION) 43

TABLE 15 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 44

TABLE 16 GLOBAL NERVE REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 45

TABLE 17 GLOBAL NERVE REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 46

TABLE 18 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 47

TABLE 19 AMERICAS: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 48

TABLE 20 AMERICAS: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 49

TABLE 21 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 49

TABLE 22 AMERICAS: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 50

TABLE 23 AMERICAS: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 50

TABLE 24 AMERICAS: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 51

TABLE 25 AMERICAS: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 51

TABLE 26 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 52

TABLE 27 AMERICAS: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 52

TABLE 28 AMERICAS: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 53

TABLE 29 NORTH AMERICA: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 53

TABLE 30 NORTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 54

TABLE 31 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 54

TABLE 32 NORTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 55

TABLE 33 NORTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 55

TABLE 34 NORTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 56

TABLE 35 NORTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 56

TABLE 36 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 57

TABLE 37 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 57

TABLE 38 NORTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 58

TABLE 39 US: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 58

TABLE 40 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 59

TABLE 41 US: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 59

TABLE 42 US: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 60

TABLE 43 US: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 60

TABLE 44 US: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 61

TABLE 45 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 61

TABLE 46 US: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 62

TABLE 47 US: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 62

TABLE 48 CANADA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 63

TABLE 49 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 63

TABLE 50 CANADA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 64

TABLE 51 CANADA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 64

TABLE 52 CANADA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 65

TABLE 53 CANADA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 65

TABLE 54 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 66

TABLE 55 CANADA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 66

TABLE 56 CANADA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 67

TABLE 57 SOUTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 67

TABLE 58 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 68

TABLE 59 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 68

TABLE 60 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 69

TABLE 61 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 69

TABLE 62 SOUTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 70

TABLE 63 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 70

TABLE 64 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 71

TABLE 65 SOUTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 71

TABLE 66 EUROPE: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 72

TABLE 67 EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 73

TABLE 68 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 73

TABLE 69 EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 74

TABLE 70 EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 74

TABLE 71 EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 75

TABLE 72 EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 75

TABLE 73 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 76

TABLE 74 EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 76

TABLE 75 EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 77

TABLE 76 WESTERN EUROPE: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 77

TABLE 77 WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 78

TABLE 78 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 78

TABLE 79 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 79

TABLE 80 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 79

TABLE 81 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 80

TABLE 82 WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 80

TABLE 83 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,

BY TYPE, 2023–2030 (USD MILLION) 81

TABLE 84 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 81

TABLE 85 WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 82

TABLE 86 GERMANY: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 82

TABLE 87 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 83

TABLE 88 GERMANY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 83

TABLE 89 GERMANY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 84

TABLE 90 GERMANY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 84

TABLE 91 GERMANY: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 85

TABLE 92 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 85

TABLE 93 GERMANY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 86

TABLE 94 GERMANY: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 86

TABLE 95 FRANCE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 87

TABLE 96 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 87

TABLE 97 FRANCE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 88

TABLE 98 FRANCE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 88

TABLE 99 FRANCE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 89

TABLE 100 FRANCE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 89

TABLE 101 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 90

TABLE 102 FRANCE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 90

TABLE 103 FRANCE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 91

TABLE 104 ITALY: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91

TABLE 105 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 92

TABLE 106 ITALY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 92

TABLE 107 ITALY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 93

TABLE 108 ITALY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 93

TABLE 109 ITALY: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 94

TABLE 110 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 94

TABLE 111 ITALY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 95

TABLE 112 ITALY: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 95

TABLE 113 SPAIN: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 96

TABLE 114 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 96

TABLE 115 SPAIN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 97

TABLE 116 SPAIN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 97

TABLE 117 SPAIN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 98

TABLE 118 SPAIN: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 98

TABLE 119 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 99

TABLE 120 SPAIN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 99

TABLE 121 SPAIN: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 100

TABLE 122 UK: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 100

TABLE 123 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 101

TABLE 124 UK: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 101

TABLE 125 UK: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 102

TABLE 126 UK: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 102

TABLE 127 UK: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 103

TABLE 128 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 103

TABLE 129 UK: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 104

TABLE 130 UK: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 104

TABLE 131 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 105

TABLE 132 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 105

TABLE 133 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 106

TABLE 134 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 106

TABLE 135 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 107

TABLE 136 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 107

TABLE 137 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION

SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 108

TABLE 138 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 108

TABLE 139 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 109

TABLE 140 EASTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 109

TABLE 141 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 110

TABLE 142 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 110

TABLE 143 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 111

TABLE 144 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 111

TABLE 145 EASTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 112

TABLE 146 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,

BY TYPE, 2023–2030 (USD MILLION) 112

TABLE 147 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 113

TABLE 148 EASTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 113

TABLE 149 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114

TABLE 150 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 115

TABLE 151 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 115

TABLE 152 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 116

TABLE 153 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 116

TABLE 154 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 117

TABLE 155 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117

TABLE 156 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 118

TABLE 157 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 118

TABLE 158 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 119

TABLE 159 CHINA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 119

TABLE 160 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 120

TABLE 161 CHINA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 120

TABLE 162 CHINA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 121

TABLE 163 CHINA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 121

TABLE 164 CHINA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 122

TABLE 165 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 122

TABLE 166 CHINA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 123

TABLE 167 CHINA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 123

TABLE 168 JAPAN: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 124

TABLE 169 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 124

TABLE 170 JAPAN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 125

TABLE 171 JAPAN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 125

TABLE 172 JAPAN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 126

TABLE 173 JAPAN: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 126

TABLE 174 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 127

TABLE 175 JAPAN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 127

TABLE 176 JAPAN: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 128

TABLE 177 INDIA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 128

TABLE 178 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 129

TABLE 179 INDIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 129

TABLE 180 INDIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 130

TABLE 181 INDIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 130

TABLE 182 INDIA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131

TABLE 183 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 131

TABLE 184 INDIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 132

TABLE 185 INDIA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 132

TABLE 186 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 133

TABLE 187 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 133

TABLE 188 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 134

TABLE 189 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 134

TABLE 190 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 135

TABLE 191 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135

TABLE 192 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,

BY TYPE, 2023–2030 (USD MILLION) 136

TABLE 193 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 136

TABLE 194 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 137

TABLE 195 AUSTRALIA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 137

TABLE 196 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 138

TABLE 197 AUSTRALIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 138

TABLE 198 AUSTRALIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 139

TABLE 199 AUSTRALIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 139

TABLE 200 AUSTRALIA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140

TABLE 201 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 140

TABLE 202 AUSTRALIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 141

TABLE 203 AUSTRALIA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 141

TABLE 204 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 142

TABLE 205 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 142

TABLE 206 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 143

TABLE 207 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 143

TABLE 208 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 144

TABLE 209 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144

TABLE 210 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,

BY TYPE, 2023–2030 (USD MILLION) 145

TABLE 211 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 145

TABLE 212 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 146

TABLE 213 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 147

TABLE 214 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148

TABLE 215 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES,

BY TYPE, 2023–2030 (USD MILLION) 148

TABLE 216 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 149

TABLE 217 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 149

TABLE 218 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 150

TABLE 219 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150

TABLE 220 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION

SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 151

TABLE 221 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 151

TABLE 222 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 152

TABLE 223 MIDDLE EAST: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152

TABLE 224 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 153

TABLE 225 MIDDLE EAST: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 153

TABLE 226 MIDDLE EAST: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 154

TABLE 227 MIDDLE EAST: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 154

TABLE 228 MIDDLE EAST: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155

TABLE 229 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES,

BY TYPE, 2023–2030 (USD MILLION) 155

TABLE 230 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 156

TABLE 231 MIDDLE EAST: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 156

TABLE 232 AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 157

TABLE 233 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE,

2023–2030 (USD MILLION) 157

TABLE 234 AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 158

TABLE 235 AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 158

TABLE 236 AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 159

TABLE 237 AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159

TABLE 238 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE,

2023–2030 (USD MILLION) 160

TABLE 239 AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 160

TABLE 240 AFRICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 161

13 List of Figures

FIGURE 1 GLOBAL NERVE REGENERATION MARKET: MARKET STRUCTURE 17

FIGURE 2 RESEARCH PROCESS OF MRFR 18

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 21

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET 22

FIGURE 5 VALUE CHAIN: GLOBAL NERVE REGENERATION MARKET 25

FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET 27

FIGURE 7 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2023 & 2030 (USD MILLION) 30

FIGURE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2023 & 2030 (USD MILLION) 37

FIGURE 9 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2023 & 2030 (USD MILLION) 44

FIGURE 10 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2023 & 2030 (USD MILLION) 47

FIGURE 11 AMERICAS: NERVE REGENERATION MARKET SHARE, BY REGION, 2023 (%) 48

FIGURE 12 EUROPE: NERVE REGENERATION MARKET SHARE, BY REGION, 2023 (%) 72

FIGURE 13 ASIA–PACIFIC: NERVE REGENERATION MARKET SHARE, BY COUNTRY, 2023 (%) 114

FIGURE 14 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET SHARE, BY REGION, 2023 (%) 147

FIGURE 15 GLOBAL NERVE REGENERATION MARKET COMPANY SHARE ANALYSIS, 2023 (%) 162